Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 7
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL).
De Corso E, Pasquini E, Trimarchi M, La Mantia I, Pagella F, Ottaviano G, Garzaro M, Pipolo C, Torretta S, Seccia V, Cantone E, Ciofalo A, Lucidi D, Fadda GL, Pafundi PC, Settimi S, Montuori C, Anastasi F, Pagliuca G, Ghidini A, Cavaliere C, Maffei M, Bussu F, Gallo S, Canevari FRM, Paludetti G, Galli J; Dupireal Italian Study Group. De Corso E, et al. Among authors: montuori c. Allergy. 2023 Oct;78(10):2669-2683. doi: 10.1111/all.15772. Epub 2023 May 26. Allergy. 2023. PMID: 37203259
How to manage recurrences after surgery in CRSwNP patients in the biologic era: a narrative review.
De Corso E, Settimi S, Montuori C, Cantiani A, Corbò M, Di Bella GA, Sovardi F, Pagella F, Rigante M, Passali GC, Paludetti G, Galli J. De Corso E, et al. Among authors: montuori c. Acta Otorhinolaryngol Ital. 2023 Apr;43(Suppl. 1):S3-S13. doi: 10.14639/0392-100X-suppl.1-43-2023-01. Acta Otorhinolaryngol Ital. 2023. PMID: 37698095 Free PMC article. Review.
Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making.
Otten J, van der Lans R, de Corso E, Dziadziulia K, Hilvering B, Weersink E, Bonini M, Hagemann J, Thaitrakool W, Montuori C, Klimek L, Reitsma S, Fokkens W. Otten J, et al. Among authors: montuori c. Expert Rev Clin Immunol. 2023 Jul-Dec;19(8):1041-1049. doi: 10.1080/1744666X.2023.2218617. Epub 2023 May 29. Expert Rev Clin Immunol. 2023. PMID: 37226507
Switching of biological therapy to dupilumab in comorbid patients with severe asthma and CRSwNP.
Rosso C, De Corso E, Conti V, Nitro L, Saibene AM, Parazzini E, Rinaldo R, De Pascalis S, Arnone F, Centanni S, Montuori C, D'Auria LM, Felisati G, Pipolo C. Rosso C, et al. Among authors: montuori c. Eur Arch Otorhinolaryngol. 2024 Jun;281(6):3017-3023. doi: 10.1007/s00405-024-08461-y. Epub 2024 Feb 12. Eur Arch Otorhinolaryngol. 2024. PMID: 38347197 Free PMC article.
Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A "Real-Life" Observational Study in the First Year of Treatment.
De Corso E, Settimi S, Montuori C, Corbò M, Passali GC, Porru DP, Lo Verde S, Spanu C, Penazzi D, Di Bella GA, Nucera E, Bonini M, Paludetti G, Galli J. De Corso E, et al. Among authors: montuori c. J Clin Med. 2022 May 10;11(10):2684. doi: 10.3390/jcm11102684. J Clin Med. 2022. PMID: 35628815 Free PMC article.
14 results